Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07166107 · ClinicalTrials.gov registry record · NA
EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living Centers
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 1,161
- Enrollment target
NCT07166107: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07166107 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 1,161 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07166107, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 1,161 participants
- Enrollment target
Study Summary
The investigators developed EVOLV-Rx (Evaluating Opportunities to Decrease Low-Value Prescribing), a novel clinical support tool to detect 18 evidence-based and clinically useful low-value prescribing practices in older adults. The objective is to conduct a hybrid study to assess the effectiveness and implementation of an EVOLV-Rx-based intervention to reduce LVP among older Veterans who reside in CLCs in VISN 4. In Aim 1, the investigators will conduct focus groups of VISN 4 CLC leaders, clinicians, Veterans, and family caregivers, where the investigators will characterize the patient, clinician, and CLC-level barriers to and facilitators of implementation; and identify and tailor strategies to optimize the intervention's adoption and implementation. In Aim 2, the investigators will conduct a hybrid type 2 effectiveness implementation trial to compare the intervention to usual care, using a stepped wedge design in five VISN 4 CLCs. The primary effectiveness outcome is the count of low-value prescribing practices per 100 Veterans. In Aim 3, the investigators will conduct an embedded process evaluation to study implementation processes, their impact on outcomes, and iteratively improve the implementation of the intervention. The investigators will also conduct semi-structured interviews of clinicians, Veterans, and family caregivers to characterize the appropriateness, feasibility, acceptability, and perceived effectiveness of the intervention and implementation strategies employed.
Interventions
- OTHER EVOLV-Rx dashboard
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,161 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2028-12-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07166107
The ClinicalTrials.gov registry entry for NCT07166107 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 1,161 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which EVOLV-Rx dashboard is the first listed.
NCT07166107 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07166107 about?
NCT07166107 is a clinical study titled "EVOLV-Rx VA: Evaluating Opportunities to Decrease Low-Value Prescribing in Community Living Centers". The investigators developed EVOLV-Rx (Evaluating Opportunities to Decrease Low-Value Prescribing), a novel clinical support tool to detect 18 evidence-based and clinically useful low-value prescribing practices in older adults. The objective is to conduct a hybrid study to assess the effectiveness a...
What is the current status of trial NCT07166107?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 1,161 participants. The study started on 2026-09-01. Estimated completion is 2028-12-31.
What interventions are being tested in trial NCT07166107?
The interventions under investigation include: EVOLV-Rx dashboard (OTHER).
Who is sponsoring clinical trial NCT07166107?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.